Fast accesses

2019, Mumbai

Welcome to Pharmasafe India 2019

Conference on anti-counterfeiting & brand protection

file

As the Indian pharmaceutical industry, growing at an annual CAGR of around 15% is constantly evolving and investing in R&D to become an ever more formidable player globally, counterfeiting remains an ever increasing challenge.

Pharmaceutical counterfeiting is multi-billion-dollar enterprise globally resulting in huge revenue loss to pharma companies, while at the same time posing grave health risks to the patient which diminishes confidence in the brand, estimated 1 out of 5 drugs sold in India and in the developing world are counterfeit is itself a wakeup call.

The third annual edition of pharmasafe India will bring together over 150 delegates and speakers representing cross-section of stakeholders – business leaders from top pharmaceutical companies, eminent experts in anti-counterfeiting technology, government & regulatory authorities, customs, investigators, legal experts, consultants and leading industry bodies to share a common platform for discussions, exchange of valuable insights, best practices, domestic and global trends and challenges as well as strategies to tackle the counterfeiting challenge. 

Messe Frankfurt uses cookies to provide you the best possible browsing experience. By using our services, you consent to our use of cookies. More information
OK